Elma Meershoek-Klein Kranenbarg
Overview
Explore the profile of Elma Meershoek-Klein Kranenbarg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
3938
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Meijer R, Faber R, Bijlstra O, Braak J, Meershoek-Klein Kranenbarg E, Putter H, et al.
BMJ Open
. 2022 Apr;
12(4):e051144.
PMID: 35365509
Introduction: Anastomotic leakage (AL) is one of the major complications after colorectal surgery. Compromised tissue perfusion at the anastomosis site increases the risk of AL. Several cohort studies have shown...
22.
van Amelsfoort R, Walraven I, Kieffer J, Jansen E, Cats A, van Grieken N, et al.
J Natl Compr Canc Netw
. 2022 Mar;
20(3):261-267.
PMID: 35276669
Background: The evaluation of health-related quality of life (HRQoL) in clinical trials has become increasingly important because it addresses the impact of treatment from the patient's perspective. The primary aim...
23.
Oosterveer T, van Erp G, Hendriks P, Broersen A, Overduin C, van Rijswijk C, et al.
Cardiovasc Intervent Radiol
. 2022 Mar;
45(5):606-612.
PMID: 35233662
Purpose: The primary objective is to determine the minimal ablation margin required to achieve a local recurrence rate of < 10% in patients with hepatocellular carcinoma undergoing thermal ablation. Secondary...
24.
Biesma H, Soeratram T, Sikorska K, Caspers I, van Essen H, Egthuijsen J, et al.
Gastric Cancer
. 2022 Feb;
25(3):640-651.
PMID: 35129727
Background: Epstein-Barr virus positivity (EBV+) and microsatellite instability (MSI-high) are positive prognostic factors for survival in resectable gastric cancer (GC). However, benefit of perioperative treatment in patients with MSI-high tumors...
25.
Esgueva A, Noordhoek I, Meershoek-Klein Kranenbarg E, Espinosa-Bravo M, Matrai Z, Zhygulin A, et al.
Ann Surg Oncol
. 2021 Nov;
29(3):1722-1734.
PMID: 34748122
Introduction: Nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) is increasingly used for both breast cancer (TNSM) and risk reduction (RRNSM). The aim of the study is to report the...
26.
Slagter A, Vollebergh M, Caspers I, van Sandick J, Sikorska K, Lind P, et al.
Gastric Cancer
. 2021 Oct;
25(2):401-410.
PMID: 34714423
Aim: To evaluate the prognostic value of tumor markers in a European cohort of patients with resectable gastric cancer. Methods: We performed a post hoc analysis of the CRITICS trial,...
27.
Caspers I, Sikorska K, Slagter A, van Amelsfoort R, Meershoek-Klein Kranenbarg E, van de Velde C, et al.
Cancers (Basel)
. 2021 Sep;
13(18).
PMID: 34572852
Gastric cancer (GC) patients at high risk of developing peritoneal metastasis (PM) as a single site of metastasis after curative treatment may be candidates for adjuvant prophylactic strategies. Here we...
28.
Hagenaars S, de Groot S, Cohen D, Dekker T, Charehbili A, Meershoek-Klein Kranenbarg E, et al.
Int J Cancer
. 2021 May;
149(5):1181-1188.
PMID: 34043821
The tumor-stroma ratio (TSR) has proven to be a strong prognostic factor in breast cancer, demonstrating better survival for patients with stroma-low tumors. Since the role of the TSR as...
29.
Flanagan M, Clancy C, Sorensen J, Thompson L, Meershoek-Klein Kranenbarg E, van de Velde C, et al.
Ann Surg Oncol
. 2021 Mar;
28(9):5238-5249.
PMID: 33712984
Background: There is no consensus on the use of neoadjuvant radiotherapy for tumors of the upper third of the rectum. Due to conflicting findings in high-quality trials and significant long-term...
30.
Bahadoer R, Dijkstra E, van Etten B, Marijnen C, Putter H, Meershoek-Klein Kranenbarg E, et al.
Lancet Oncol
. 2021 Mar;
22(3):e90-e91.
PMID: 33662297
No abstract available.